BRIDGEWAY CAPITAL MANAGEMENT, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2023$79,500
-72.0%
50,000
-83.3%
0.00%
-75.0%
Q3 2022$284,000
-2.1%
299,000
+23.6%
0.01%
+14.3%
Q2 2022$290,000
-8.5%
242,0000.0%0.01%
+16.7%
Q1 2022$317,000
-73.0%
242,000
+8.2%
0.01%
-60.0%
Q1 2019$1,172,000
+96.6%
223,600
+18.2%
0.02%
+87.5%
Q4 2018$596,000
-47.9%
189,2000.0%0.01%
-27.3%
Q3 2018$1,145,000
+14.2%
189,2000.0%0.01%
+10.0%
Q2 2018$1,003,000
-8.6%
189,2000.0%0.01%
-16.7%
Q1 2018$1,097,000
+70.3%
189,200
+2.9%
0.01%
+71.4%
Q4 2017$644,000
-4.0%
183,9000.0%0.01%
-12.5%
Q3 2017$671,000
+45.9%
183,9000.0%0.01%
+33.3%
Q2 2017$460,000
-7.4%
183,9000.0%0.01%0.0%
Q1 2017$497,000
-52.8%
183,900
-49.4%
0.01%
-57.1%
Q4 2016$1,054,000
-24.7%
363,400
+6.8%
0.01%
-33.3%
Q3 2016$1,399,000
+218.7%
340,297
+144.7%
0.02%
+200.0%
Q2 2016$439,000139,0390.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders